137 related articles for article (PubMed ID: 22139790)
1. Prevalence of diagnosed adult immune thrombocytopenia in the United Kingdom.
Bennett D; Hodgson ME; Shukla A; Logie JW
Adv Ther; 2011 Dec; 28(12):1096-104. PubMed ID: 22139790
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database.
Schoonen WM; Kucera G; Coalson J; Li L; Rutstein M; Mowat F; Fryzek J; Kaye JA
Br J Haematol; 2009 Apr; 145(2):235-44. PubMed ID: 19245432
[TBL] [Abstract][Full Text] [Related]
3. The incidence of idiopathic thrombocytopenic purpura among adults: a population-based study and literature review.
Abrahamson PE; Hall SA; Feudjo-Tepie M; Mitrani-Gold FS; Logie J
Eur J Haematol; 2009 Aug; 83(2):83-9. PubMed ID: 19245532
[TBL] [Abstract][Full Text] [Related]
4. Risk of cataract among idiopathic thrombocytopenic purpura patients in the UK general practice research database.
Feudjo-Tepie MA; Hall SA; Logie J; Robinson NJ
Pharmacoepidemiol Drug Saf; 2009 May; 18(5):380-5. PubMed ID: 19241439
[TBL] [Abstract][Full Text] [Related]
5. Length of stay, hospitalization cost, and in-hospital mortality in US adult inpatients with immune thrombocytopenic purpura, 2006-2012.
An R; Wang PP
Vasc Health Risk Manag; 2017; 13():15-21. PubMed ID: 28176930
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database.
Yong M; Schoonen WM; Li L; Kanas G; Coalson J; Mowat F; Fryzek J; Kaye JA
Br J Haematol; 2010 Jun; 149(6):855-64. PubMed ID: 20377590
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the impact and burden of illness of adult chronic ITP in the US.
Saleh MN; Fisher M; Grotzinger KM
Curr Med Res Opin; 2009 Dec; 25(12):2961-9. PubMed ID: 19835465
[TBL] [Abstract][Full Text] [Related]
8. The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports.
Terrell DR; Beebe LA; Vesely SK; Neas BR; Segal JB; George JN
Am J Hematol; 2010 Mar; 85(3):174-80. PubMed ID: 20131303
[TBL] [Abstract][Full Text] [Related]
9. Immune thrombocytopenia: epidemiological and clinical features of 216 patients in northwestern Turkey.
Koylu A; Pamuk GE; Uyanik MS; Demir M; Pamuk ON
Ann Hematol; 2015 Mar; 94(3):459-66. PubMed ID: 25238800
[TBL] [Abstract][Full Text] [Related]
10. Measurement of utility values in the UK for health states related to immune thrombocytopenic purpura.
Szende A; Brazier J; Schaefer C; Deuson R; Isitt JJ; Vyas P
Curr Med Res Opin; 2010 Aug; 26(8):1893-903. PubMed ID: 20553121
[TBL] [Abstract][Full Text] [Related]
11. Twenty-year mortality of adult patients with primary immune thrombocytopenia: a Danish population-based cohort study.
Frederiksen H; Maegbaek ML; Nørgaard M
Br J Haematol; 2014 Jul; 166(2):260-7. PubMed ID: 24690142
[TBL] [Abstract][Full Text] [Related]
12. Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort.
Moulis G; Germain J; Comont T; Brun N; Dingremont C; Castel B; Arista S; Sailler L; Lapeyre-Mestre M; Beyne-Rauzy O; Godeau B; Adoue D;
Am J Hematol; 2017 Jun; 92(6):493-500. PubMed ID: 28240787
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic thrombocytopenic purpura is strongly associated with higher prevalence of aortic valve disease.
Haseefa F; Movahed MR; Hashemzadeh M; Hashemzadeh M
Ann Hematol; 2020 Sep; 99(9):2081-2084. PubMed ID: 32691113
[TBL] [Abstract][Full Text] [Related]
14. Presentation and outcome of idiopathic thrombocytopenic purpura in a single Australian centre.
Choi PY; Gordon JE; Harvey M; Chong BH
Intern Med J; 2012 Jul; 42(7):841-5. PubMed ID: 22805691
[TBL] [Abstract][Full Text] [Related]
15. Management of immune thrombocytopenia in adults: a population-based analysis of the French hospital discharge database from 2009 to 2012.
Michel M; Suzan F; Adoue D; Bordessoule D; Marolleau JP; Viallard JF; Godeau B
Br J Haematol; 2015 Jul; 170(2):218-22. PubMed ID: 25824587
[TBL] [Abstract][Full Text] [Related]
16. Chronic immune thrombocytopenia in adults: epidemiology and clinical presentation.
Fogarty PF
Hematol Oncol Clin North Am; 2009 Dec; 23(6):1213-21. PubMed ID: 19932429
[TBL] [Abstract][Full Text] [Related]
17. Primary immune thrombocytopenia in US clinical practice: incidence and healthcare burden in first 12 months following diagnosis.
Weycker D; Hanau A; Hatfield M; Wu H; Sharma A; Bensink ME; Chandler D; Grossman A; Tarantino M
J Med Econ; 2020 Feb; 23(2):184-192. PubMed ID: 31547724
[No Abstract] [Full Text] [Related]
18. Hepatobiliary laboratory abnormalities among patients with chronic or persistent immune thrombocytopenia (ITP).
Enger C; Bennett D; Dawson KL; Aivado MA; Theodore D; McAfee AT
Ann Hepatol; 2011; 10(2):188-95. PubMed ID: 21502681
[TBL] [Abstract][Full Text] [Related]
19. Renal impairment, hemoglobinuria, and hemoglobinemia among patients with idiopathic thrombocytopenic purpura.
Xue F; Wentworth C; Ganesh V; Gastanaga V; Stryker S; Cha S; Zhao S
Am J Hematol; 2011 Sep; 86(9):738-42. PubMed ID: 21786287
[TBL] [Abstract][Full Text] [Related]
20. Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura.
Danese MD; Lindquist K; Gleeson M; Deuson R; Mikhael J
Am J Hematol; 2009 Oct; 84(10):631-5. PubMed ID: 19705429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]